Open original FDA record ↗Recall record
- FDA identifier
- Z-0956-2026
- Company in FDA record
- Myofunctional Research Company USA
- FDA classification date
- Dec 18, 2025
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Due to firm mistakenly distributing product within the U.S. without FDA premarket clearance/approval.
Source facts
- Action
- On 10/09/2025, the firm emailed an "URGENT: Medical Device Recall" letter to customers informing them that products (Myosa for Kids KS1 and Myosa for Kids KS2) were distributed in the United States without the required FDA premarket clearance. Customers are instructed to: 1. Immediately examine their inventory for the affected products. 2. Cease distribution/use of any remaining Myosa KS1 and KS2 devices. 3. Quarantine affected stock to prevent further use. 4. Complete and return the enclosed Response Form within 10 business days, even if customers no longer have any affected product. 5. Return quarantine devices using the instructions provided after receipt of customer response forms For any patient who has initiated treatment with the affected devices or to whom you have not explained the risks associated with these devices, it is requested that you notify them and provide warning s and clinical alternatives as appropriate. For questions and/or assistance - Contact Recall Coordinator at 909-587-4940 or email usa.hq@myoresearch.com
- Initiated
- 2025-10-09
- Root cause
- No Marketing Application
- Distribution
- U.S. (nationwide) distribution to states of: Nationwide: AK, AR, CA, CO, FL, GA, HI, IL, KS, KY, LA, MA, MD, MI, MN, NC, NJ, NM, NY, OH, OR, PA, TX, UT, VA, and WA; O.U.S. (foreign) to country of: Australia
- Recall number
- Z-0956-2026
- Recall status
- Open, Classified
- CDRH record ID
- 217421
- FDA classified
- 2025-12-18
- Recall event number
- 97890